Title : Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1.

Pub. Date : 2019 Feb 7

PMID : 30733557






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crystallographic analysis reveals that this specificity is achieved through direct binding of MEDI-579 Fab to the reactive centre loop (RCL) of PAI-1 and at the same exosite used by both tissue and urokinase plasminogen activators (tPA and uPA). Tetradecanoylphorbol Acetate serpin family E member 1 Homo sapiens
2 We propose that MEDI-579 acts by directly competing with proteases for RCL binding and as such is able to modulate the interaction of PAI-1 with tPA and uPA in a way not previously described for a human PAI-1 inhibitor. Tetradecanoylphorbol Acetate serpin family E member 1 Homo sapiens
3 We propose that MEDI-579 acts by directly competing with proteases for RCL binding and as such is able to modulate the interaction of PAI-1 with tPA and uPA in a way not previously described for a human PAI-1 inhibitor. Tetradecanoylphorbol Acetate serpin family E member 1 Homo sapiens